PLT Health Solutions has announced that its Rhodiola rosea ingredients comply with the new regulations imposed by the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES). CITES is an international agreement that regulates the trade of plants and animals to protect endangered species. The Appendix II list, updated in November 2022, now includes new botanicals such as Rhodiola rosea, which must adhere to licensing and certification schemes to minimize their impact on wild populations. To comply with these new rules, PLT collaborated with partner Nektium and various global government institutions.
Rhodiola rosea is a popular herb used in traditional medicine and health supplements, known for its ability to enhance mental and physical performance. However, its increasing demand has led to overharvesting and illegal trade, threatening wild populations. The inclusion of Rhodiola rosea in CITES Appendix II reflects the need for more sustainable and responsible sourcing of this species.
By offering CITES-compliant Rhodiola rosea, PLT Health Solutions is taking a step towards promoting ethical and environmentally conscious trade practices. Through their partnership with Nektium and global government institutions, they have demonstrated their commitment to preserving wild populations while meeting the growing demand for this popular ingredient.
